STOCK TITAN

Director Paul Bisaro receives 1,936 Zoetis (ZTS) restricted stock units as award

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Bisaro Paul reported acquisition or exercise transactions in this Form 4 filing.

Zoetis Inc. director Paul Bisaro reported an equity compensation award in the form of 1,936 restricted stock units on February 18, 2026. These RSUs were granted under the Zoetis Inc. Amended and Restated 2013 Equity and Incentive Plan and represent a contingent right to receive an equal number of Zoetis common shares.

Each RSU will vest and be settled in Zoetis common stock on the first anniversary of the grant date, February 18, 2026, subject to his continued service and certain earlier‑vesting events. A separate line reflects his existing RSU holdings, which totaled 1,619.3325 units after earlier grants and related dividend equivalents.

Positive

  • None.

Negative

  • None.
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Bisaro Paul

(Last) (First) (Middle)
C/O ZOETIS INC.
10 SYLVAN WAY

(Street)
PARSIPPANY NJ 07054

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Zoetis Inc. [ ZTS ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
02/18/2026
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Restricted Stock Unit(1) (2) 02/18/2026 A 1,936 (3) (4) Common Stock 1,936 $0 1,936 D
Restricted Stock Unit(1) (2) (5) (4) Common Stock 1,619.3325 1,619.3325 D
Explanation of Responses:
1. Represents restricted stock units granted pursuant to the Zoetis Inc. Amended and Restated 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs").
2. Each restricted stock unit represents a contingent right to receive one share of Zoetis Inc. common stock.
3. Each RSU will vest and be settled in shares of Zoetis Inc. common stock on the first anniversary of the date of grant, February 18, 2026; subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events.
4. Not applicable.
5. Each RSU will vest and be settled in shares of Zoetis Inc. common stock on the first anniversary of the date of grant, February 19, 2025; subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events.
Remarks:
/s/ Brenda Santuccio, as Attorney-in-Fact 02/19/2026
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Zoetis (ZTS) director Paul Bisaro report?

Zoetis director Paul Bisaro reported receiving 1,936 restricted stock units as an equity award. The grant is under the Zoetis Inc. Amended and Restated 2013 Equity and Incentive Plan and reflects compensation rather than an open-market stock purchase or sale.

When do Paul Bisaro’s new Zoetis (ZTS) restricted stock units vest?

Each of Paul Bisaro’s newly granted Zoetis restricted stock units will vest and be settled in common shares on the first anniversary of the grant date, February 18, 2026, provided he continues in service and subject to specified earlier vesting events.

How many Zoetis (ZTS) restricted stock units did Paul Bisaro receive in this Form 4?

Paul Bisaro received 1,936 restricted stock units in this transaction. Each unit represents a contingent right to receive one share of Zoetis Inc. common stock, granted as part of his director equity compensation package under the company’s equity and incentive plan.

What does each Zoetis (ZTS) restricted stock unit reported by Paul Bisaro represent?

Each restricted stock unit reported by Paul Bisaro represents a contingent right to receive one share of Zoetis Inc. common stock. The units convert into shares upon vesting, making them a form of stock-based compensation rather than immediate ownership of common shares.

Does the Zoetis (ZTS) Form 4 show any stock sales by Paul Bisaro?

The Form 4 does not report any stock sales by Paul Bisaro. It shows an acquisition of 1,936 restricted stock units as a grant and a separate holding entry for previously awarded RSUs and associated dividend equivalent units.

What prior Zoetis (ZTS) RSU grant is referenced in Paul Bisaro’s filing?

A footnote references RSUs that vest and settle on the first anniversary of a February 19, 2025 grant. These earlier restricted stock units, along with dividend equivalent units, contribute to the 1,619.3325 RSUs shown in the holding line after previous awards.
Zoetis Inc

NYSE:ZTS

ZTS Rankings

ZTS Latest News

ZTS Latest SEC Filings

ZTS Stock Data

53.73B
440.24M
Drug Manufacturers - Specialty & Generic
Pharmaceutical Preparations
Link
United States
PARSIPPANY